150 related articles for article (PubMed ID: 16011589)
1. The effect of clotting factor concentrates on the immune system in HIV-negative haemophilics.
Balkan C; Kavakli K; Kutukculer N; Aksu G; Yilmaz D; Aydinok Y
Haemophilia; 2005 Jul; 11(4):366-70. PubMed ID: 16011589
[TBL] [Abstract][Full Text] [Related]
2. [HIV infection and immunity disorders in patients with hemophilia].
Gotić M; Rolović Z; Brkić S; Vucković S; Bujko M; Lilić D; Dujić A
Srp Arh Celok Lek; 1989; 117(11-12):737-50. PubMed ID: 2490991
[TBL] [Abstract][Full Text] [Related]
3. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
Kawahara M; Matsuo K; Honda M
Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
[TBL] [Abstract][Full Text] [Related]
4. Differences in immune response between HCV positive, HIV negative haemophilia A and B patients.
Meijer K; Smid WM; Verspiek SP; Smit JW; van der Meer J
Thromb Haemost; 1998 Jan; 79(1):59-61. PubMed ID: 9459324
[TBL] [Abstract][Full Text] [Related]
5. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
6. HIV antibody status and immunological abnormalities in Polish haemophiliacs.
Lopaciuk S; Kacperska E; Gloskowska-Moraczewska Z; Maslanka K; Uhrynowska M; Kraj M; Seyfried H
Thromb Haemost; 1987 Feb; 57(1):41-3. PubMed ID: 3495899
[TBL] [Abstract][Full Text] [Related]
7. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
[TBL] [Abstract][Full Text] [Related]
8. Impaired cell-mediated immunity in Papua New Guinean infants.
Witt CS; Alpers MP
P N G Med J; 1991 Jun; 34(2):90-7. PubMed ID: 1750259
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subgroups and natural killer cell activity in recurrent herpetic stromal keratitis.
Iskeleli G; Camcioglu Y; Akova N; Kiran B; Bahar H; Deniz G
Eye Contact Lens; 2008 May; 34(3):169-73. PubMed ID: 18463483
[TBL] [Abstract][Full Text] [Related]
10. Humoral and cellular immune abnormalities in adult hemophiliacs followed over a 2-year period.
Freedman J; Mazaheri R; Read S; Garvey MB; Teitel J
Diagn Clin Immunol; 1987; 5(1):30-40. PubMed ID: 2439226
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
[TBL] [Abstract][Full Text] [Related]
12. Clotting factor concentrates and immune function in haemophilic patients.
Hoots K; Canty D
Haemophilia; 1998 Sep; 4(5):704-13. PubMed ID: 9873875
[TBL] [Abstract][Full Text] [Related]
13. High versus ultra-high purity factor VIII concentrate therapy: prospective evaluation of immunological and clinical parameters in HIV seronegative and seropositive hemophiliacs.
Varon D; Schulman S; Dardik R; Barzilai A; Bashari D; Martinowitz U
Thromb Haemost; 1994 Sep; 72(3):359-62. PubMed ID: 7855784
[TBL] [Abstract][Full Text] [Related]
14. Relationship between HLA-DRB1*0101, DRB1*0301 alleles and interleukin-12 in haemophilic patients and hepatitis C virus positive hepatocellular carcinoma patients.
Hamed NA; Hano AF; Raouf HA; Gamal M; Eissa M
Egypt J Immunol; 2003; 10(1):17-26. PubMed ID: 15719619
[TBL] [Abstract][Full Text] [Related]
15. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
16. Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patients.
Roosendaal G; van der Schouw Y; Mauser-Bunschoten E; Borleffs J; van den Berg H
Vox Sang; 1998; 75(4):261-6. PubMed ID: 9873260
[TBL] [Abstract][Full Text] [Related]
17. Immunologic studies in asymptomatic hemophiliac patients.
Frydecka I; Kowalewska B; Lesiecki A; Kuliczkowski K; Palakowska A; Polkowski A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):708-15. PubMed ID: 2435638
[TBL] [Abstract][Full Text] [Related]
18. [The effect of the type of factor VIII concentrate on the CD4 lymphocyte count in hemophiliacs with human immunodeficiency virus infection: the results of a meta-analysis].
Montoro Ronsano JB; Oliveras Martín J; Tusell Puigbert JM
Med Clin (Barc); 1994 Nov; 103(18):690-4. PubMed ID: 7808075
[TBL] [Abstract][Full Text] [Related]
19. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
[TBL] [Abstract][Full Text] [Related]
20. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole.
Feola DJ; Garvy BA; Rapp RP; Thornton AC
Pharmacotherapy; 2007 Jul; 27(7):937-47. PubMed ID: 17594199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
